Metabolic, Endocrine and GI
-
A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome.
Lewin van den Broek NT, Numans ME, Buskens E, Verheij TJ, de Wit NJ, Smout AJ. Br J Gen Pract. 2001;51(469):619-24.
-
Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients.
Vasen HF, van Duijvendijk P, Buskens E, Bulow C, Bjork J, Jarvinen HJ, Bulow S. Gut. 2001;49(2):231-5.
-
Postmenopausal hormone therapy: less favourable risk-benefit ratios in healthy Dutch women.
Moerman CJ, Van Hout BA, Bonneux L, Witteman JC. J Intern Med. 2000;248(2):143-50.
-
A short-term cost-of-treatment model for type 2 diabetes: comparison of glipizide gastrointestinal therapeutic system, metformin, and acarbose.
Ramsdell JW, Grossman JA, Stephens JM, Botteman MF, Arocho R. Am J Manag Care. 1999;5(8):1007-24.
-
Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis.
Vasen HF, Bulow S, Myrhoj T, Mathus-Vliegen L, Griffioen G, Buskens E, Taal BG, Nagengast F, Slors JF, de Ruiter P. Gut. 1997;40(6):716-9.
-
Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis.
Vasen HF, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG, Schouten WR, Oostvogel HJ, Kuijpers JH, Tops CM, Meera Khan P. Lancet. 1996;348(9025):433-5.
-
Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis.
Busschbach JJ, Horikx PE, van den Bosch JM, Brutel de la Riviere A, de Charro FT. Chest. 1994;105(3):911-7.
|
,
View by subject
|
